Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Interferon-Gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
This study is ongoing, but not recruiting participants.
Study NCT00616720 Information provided by National Cancer Institute (NCI)
First Received: February 14, 2008 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
aldesleukin
recombinant interferon gamma
polymerase chain reaction
flow cytometry
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Interferon Type II
Interferon-gamma, Recombinant
Interferons
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
Back to top of Main Content
